Ethan Russo is listed as an executive officer and director on 9 SEC Form D filings by 1 issuer between Mar 2022 and Oct 2026: Andira Medicine Inc. (North Vancouver, British Columbia, Canada (as filed: A1) — industry reported as "Other" — 2022–2026; $810K reported sold to 5 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 9 public filings for Ethan Russo and found 3 differences: Form D filed 31 days after the first sale; Ethan Russo's role changed at Andira Medicine Inc.: director → executive officer, director; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.